WILMINGTON, N.C. — TranS1, a medical device company, has filed plans for an initial public offering.
In a filing disclosed Tuesday, TranS1 said a price for stock and the number of shares to be offered had not been set. However, Private Equity Wire reported TranS1 hoped to raise $80.5 million.
The company has raised some $40 million in venture funding since it was launched in 2000. Backers include Advanced Technology Ventures, Delphi Ventures, Cutlass Capital, Sapient Capital and Thomas Weisel Healthcare Venture Partners.
The IPO will be handled by Lehman Brothers Inc. and Piper Jaffray & Co. Co-managers are Cowen and Company, LLC and Leerink Swann & Co.
TranS1 has developed a device for treating degenerative disc disease that requires minimally invasive surgery.
Medical Device Firm TranS1 Files for $80M IPO
Copyright 2007 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
-
- PC makers may face a legal challenge in ‘Green Dam’ battle from U.S. firm
Jul. 3, 2009 - As Nortel’s final demise nears, what blame should its board shoulder?
Jul. 3, 2009 - Climate change and the economy: Public policies like ‘cap and trade’ and a carbon tax could have big impacts on our wallets.
Jul. 3, 2009 - 20/20: Surgery can let you see like a child again
Jul. 3, 2009 |
- CDC: US swine flu cases rise to nearly 34,000
Jul. 3, 2009
- PC makers may face a legal challenge in ‘Green Dam’ battle from U.S. firm
-
- RTP-based Metabolon raises another $1 million in venture capital
Jul. 2, 2009 - NanoCor Therapeutics raises $2.5M
Jul. 1, 2009 - Despite three IPOs, venture-backed exits drop to trickle in second quarter
Jul. 1, 2009 - Seeking investors? Be sure to find the right angel partners
Jul. 1, 2009 - Georgia Research Alliance venture fund closes on $18.75 million
Jun. 29, 2009
- RTP-based Metabolon raises another $1 million in venture capital
More from wrallocaltechwire.com
Market Watch
advertisement


